Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a phase 3 clinical trial.
The protein makes blood vessels leakier to allow metastatic tumors to form in the lungs, according to a study led by investigators at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.
A protein that can dial down oxidative stress in cells helps some cancers resist treatment with a widely used class of drugs called BTK inhibitors, according to a study led by investigators at Weill Cornell Medicine.
An overactive immune response in the brain may play a role in Dravet syndrome, a rare and severe genetic epilepsy that typically begins in infancy, according to Weill Cornell Medicine researchers.
A new way to measure comorbidity can be used to accurately predict a patient’s risk of hospitalization and future healthcare costs across a population.
As psychedelic drugs gain more support from the medical community as a potential treatment for severe depression, Cornell researchers are making crucial discoveries that explain how compounds such as psilocybin work on the brain.
